| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Vice President
1 company
Nicholas Michael Westfall last filed a Form 4 in August 2025, as Executive Vice President at CHE. Nicholas Michael Westfall's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Nicholas Michael Westfall's trades have earned a middling insider score of 63/100 across 12 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -1.3%.
Nicholas Michael Westfall has 38 Form 4 filings on record from November 2016 to August 2025, all as Executive Vice President at Chemed (CHE), 2016–2025.
The 89 reported transactions were 38 option exercises, 20 open-market sales, 17 option or other derivative awards and 14 tax withholdings.
Counted by filing, the open-market trades come to no purchases and 16 sales worth about $52.6M.
The largest open-market sale was 24,000 shares of CHE at an average $427.08 on May 8, 2020, about $10.2M.
None of the 5 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from August 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2025 | CHE Chemed Corp | Executive Vice President | Sell | 10,012 | $421.91 | $4,224,162.92 | -100% | +4.1% | +27.5% | |
| Sep 9, 2024 | CHE Chemed Corp | Executive Vice President | Sell | 1,713 | $569.35 | $975,296.55 | -21.9% | -4.1% | -19.0% | |
| Jul 30, 2024 | CHE Chemed Corp | Executive Vice President | Sell | 2,000 | $561.58 | $1,123,160.00 | -25.0% | +7.5% | -26.4% | |
| Jun 1, 2023 | CHE Chemed Corp | Executive Vice President | Sale+OE | 12,670 | $533.70 | $6,761,979.00 | -62.3% | -3.6% | +3.9% | |
| May 30, 2023 | CHE Chemed Corp | Executive Vice President | Sale+OE | 1,330 | $540.34 | $718,652.20 | -17.3% | -4.3% | +2.1% | |
| Nov 3, 2022 | CHE Chemed Corp | Executive Vice President | Sale+OE | 13,500 | $477.19 | $6,442,065.00 | -65.9% | +6.4% | +22.2% | |
| May 10, 2022 | CHE Chemed Corp | Executive Vice President | Sell | 1,432 | $500.10 | $716,143.20 | -17.0% | -4.4% | +10.3% | |
| Nov 3, 2021 | CHE Chemed Corp | Executive Vice President | Sale+OE | 5,594 | $486.48 | $2,721,394.94 | -74.8% | -3.7% | -0.7% | |
| Jun 8, 2021 | CHE Chemed Corp | Executive Vice President | Sale+OE | 2,708 | $485.04 | $1,313,488.32 | -73.1% | -4.2% | -2.1% | |
| Jun 7, 2021 | CHE Chemed Corp | Executive Vice President | Sell | 3,771 | $493.10 | $1,859,468.79 | -50.4% | -4.5% | -0.9% |